Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
SRI International Announces Drug Research Collaboration with Ionis Pharmaceuticals
Wednesday, July 11, 2018SRI International today announced a research agreement with Ionis Pharmaceuticals combining SRIs proprietary FOX Three Molecular Guidance cellular targeting system MGS with Ionis proprietary antisense drugdiscovery platform SRIs FOX Three MGS tech...
Teva Announces Launch of a Generic Version of Uceris® in the United States
Tuesday, July 10, 2018Teva Pharmaceutical Industries Ltd today announced the launch of a generic version of Uceris budesonide extendedrelease tablets mg in the US Budesonide extendedrelease tablets are a glucocorticosteroid indicated for the induction of remission in...
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon® Patch
Tuesday, July 10, 2018Mylan NV today announced the US launch of Rivastigmine Transdermal System mg hrs mg hrs and mg hrs a generic version of Novartis Exelon Patch Mylan received final approval from the US Food and Drug Administration FDA for its Abbreviated New Drug A...
OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Hepatocellular Carcinoma (HCC)
Monday, July 09, 2018OBI Pharma Inc a Taiwan biopharma company today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation for OBI for the Treatment of Hepatocellular Carcinoma HCC OBI is a first in class DNA alkylating cancer therape...
Cleara Biotech Announces Three Collaborations to Develop New Therapeutics Targeting Senescent Cells and Cancer
Saturday, July 07, 2018Cleara Biotech BV Cleara a Netherlandsbased biopharmaceutical company announced today the creation of three publicprivate partnerships to discover and develop new therapeutics Cleara has partnered with Dr Peter de Keizer from the University Medical C...
Eisai And Biogen Announce Positive Topline Results Of The Final Analysis For BAN2401 At 18 Months
Friday, July 06, 2018Eisai Co Ltd and Biogen Inc announced positive topline results from the Phase II study with BAN an antiamyloid beta protofibril antibody in patients with early Alzheimers disease The study achieved statistical significance on key predefined endpoint...
Neovii & Mundipharma Confirm In-licensing Agreement for the Development and Promotion of Grafalon(R) in China and Japan
Friday, July 06, 2018Neovii pharmaceuticals AG of Rapperswil Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon in China and Japan from end October Grafa...
Forendo Pharma Initiates Phase I Study for Potential New, Targeted Treatment for Endometriosis
Thursday, July 05, 2018Forendo Pharma a drug development company focusing on novel oral treatments for endometriosis patients today announces it has received clinical trial authorisation CTA from the UKs Medicines and Healthcare products Regulatory Agency MHRA to commence...
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA® (Tesamorelin for Injection) for FDA Approval
Thursday, July 05, 2018Theratechnologies Inc today announced that it has filed a supplemental new drug application sNDA with the Food and Drug Administration FDA for a singlevial formulation of EGRIFTA The filing is based on bioequivalence studies which were completed e...
Menarini and Orion Sign Regional Partnerships in Asia-Pacific
Wednesday, July 04, 2018A Menarini AsiaPacific Holdings Pte Ltd a member of the Italian largest biopharmaceutical company Menarini Group and Orion Corporation have signed a multiyear licensing agreement for Menarini AsiaPacific to distribute and commercialize several of Or...
